vancomycin has been researched along with guaifenesin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Donskey, CJ; Gries, DM; Pultz, NJ | 1 |
| Alshareef, A; Fitzgerald, N; Hayward, A; Hwang, AV; Ishida, K; Jenkins, J; Kang, Z; Kuosmanen, J; Langer, R; Lennerz, J; Liu, S; Madani, WAM; Morimoto, J; Srinivasan, SS; Traverso, G | 1 |
1 review(s) available for vancomycin and guaifenesin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for vancomycin and guaifenesin
| Article | Year |
|---|---|
Growth in cecal mucus facilitates colonization of the mouse intestinal tract by methicillin-resistant Staphylococcus aureus.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cecum; Female; Intestinal Mucosa; Methicillin; Methicillin Resistance; Mice; Mucus; Staphylococcus aureus; Streptomycin; Vancomycin | 2005 |
RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract.
Topics: Administration, Oral; Animals; Gastrointestinal Tract; Insulin; Mucus; Nanoparticles; Peptides; Robotic Surgical Procedures; Swine; Vancomycin | 2022 |